Labcorp (LH) stock
NYSE
As of the Nov 13, 2026 close (U.S. Eastern)
- Market cap
- $30B
- As of Nov 13, 2026
- P/E
- 29.86x
- Trailing twelve months
- P/B
- 3.39x
- Latest reported equity
- P/S
- 2.06x
- Trailing twelve months
- ROE
- 11.4%
- Trailing twelve months
- Dividend yield
- 0.78%
- Latest fiscal-year dividends
Multiples use the price as of Nov 13, 2026 and may differ from the current price.
- Market cap
- $30B
- As of Nov 13, 2026
- P/E
- 29.86x
- Trailing twelve months
- P/B
- 3.39x
- Latest reported equity
- P/S
- 2.06x
- Trailing twelve months
- ROE
- 11.4%
- Trailing twelve months
- Dividend yield
- 0.78%
- Latest fiscal-year dividends
Multiples use the price as of Nov 13, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 13, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
29.86x
P/B
3.39x
P/S
2.06x
Earnings and dividend metrics▾
Earnings
EPS
$12.41
Earnings per share
BPS
$109.23
Book value per share
ROE
11.4%
Return on equity
- EPS — what one share earned over the last four quarters. This company earned $12.41 per share.
- BPS — net assets divided by the number of shares. Each share is backed by $109.23 of net assets.
- ROE — how much the company earned on shareholder equity over a year: 11.4%.
Dividends
Yield
0.78%
Dividend per share
$2.88
Payout ratio
24.0%
Consecutive years
4+ yrs
Yield uses fiscal 2025 dividends · Dividend per share and payout ratio are for fiscal 2025.
- Dividend yield — dividends divided by the share price (or market cap). It falls when the price rises.
- Dividend per share — the fiscal-year dividend per share. For one hundred shares that is about $288.00 before tax.
- Payout ratio — 24.0% of earnings was paid out as dividends.
- Consecutive years — dividends were paid every year for more than 4 years. That does not mean they will continue.
Reference only · not a promise of future dividends
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from SEC financial filings: net income and revenue are summed over the latest four quarters, and equity is the latest reported balance.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Latest earnings
SEC filingsJul–Sep 2026(FY2026 Q3)
Revenue increased 6.9% from the same period a year earlier.
Key reported figures come first. Select one to see the same quarter across three years.
Revenue · same quarter, three years
Year-ago quarter $3.56B+6.9%
$3.28B
Jul–Sep '24
$3.56B
Jul–Sep '25
$3.81B
Jul–Sep '26
The next earnings date has not been confirmed yet.
ⓘ Notes on these figures▾
- Results for Jul–Sep 2026 are from the 10-Q submitted to SEC EDGAR on Oct 30, 2026.
- Earnings per share increased 3.2% from the same quarter a year earlier.
- Revenue increased 6.9% from the same quarter a year earlier.
- Operating income increased 1.3% from the same quarter a year earlier.
- Net income increased 0.8% from the same quarter a year earlier.
Filed Oct 30, 2026 · 10-Q · SEC EDGAR
Reported results are from SEC EDGAR filings. Reference information only, not investment advice.
Insider transactions
Recent Form 4 filings grouped by person, date and transaction type.
- Caveney Brian JEVP, Pres of BLS, CMO & CSO · Nov 10, 2026Open-market sale2,000 shares · $744KAvg. price $372.040134,562 shares held after
- Vaughn Bryan TEVP and President, Diagnostics · Nov 3, 2026Open-market sale306 shares · $108KAvg. price $353.76,845 shares held after
- Vaughn Bryan TEVP and President, Diagnostics · Nov 2, 2026Shares withheld for taxes194 shares · $69KAvg. price $355.597,151 shares held after
- Oyegunwa AkinboladeEVP, CIO & CTO · Nov 2, 2026Shares withheld for taxes118 shares · $42KAvg. price $355.595,316 shares held after
- Oyegunwa AkinboladeEVP, CIO & CTO · Nov 1, 2026Option exercise370 shares5,434 shares held after
- Vaughn Bryan TEVP and President, Diagnostics · Nov 1, 2026Option exercise500 shares7,345 shares held after
- Parham Richelle PDirector · Oct 30, 2026Open-market sale1,078 shares · $389KAvg. price $361.222,288 shares held after
- ANDERSON KERRII BDirector · Aug 17, 2026Open-market sale3,000 shares · $954KAvg. price $318.026,563 shares held after
- Schechter Adam HPresident & CEO · Aug 11, 2026Open-market sale4,669 shares · $1.5MAvg. price $320.37102,565 shares held after
- Summy Amy B.EVP, Chief Marketing Officer · Aug 4, 2026Open-market sale924 shares · $283KAvg. price $306.746,956 shares held after
- Wilkinson Peter JSVP, Chief Accounting Officer · Aug 3, 2026Open-market sale1,420 shares · $439KAvg. price $309.23051,770 shares held after
Show 2 price lots
- 1,338 shares × $309.2311$414K
- 82 shares × $309.22$25K
- Wilkinson Peter JSVP, Chief Accounting Officer · Aug 3, 2026Option exercise1,338 shares · $280KAvg. price $209.253,108 shares held after
Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.
Recent SEC filings
40 filingsRecent filing summaries
Newest first by publication date · may differ from the filing date
- AI summary8-KThe company said Chief Financial Officer Julia Wang will speak at the UBS Global Healthcare Conference on November 10, 2026 at 8:45 a.m. ET, announced on November 4, 2026.Published Nov 4, 2026 · Filed Nov 4, 2026Read the summary →
- AI summary8-KThe company said revenue for Q3 2026 (three months ended September 30) rose to $3,810.0 million, up 6.9% from $3,563.5 million a year earlier, with diluted EPS at $3.22 and adjusted EPS at $4.78.Published Oct 28, 2026 · Filed Oct 28, 2026Read the summary →
- AI summary8-KLabcorp said its Board of Directors declared a cash dividend of $0.72 per share of common stock on October 21, 2026.Published Oct 21, 2026 · Filed Oct 21, 2026Read the summary →
- The company said Chief Financial Officer Julia Wang will speak at the UBS Global Healthcare Conference on November 10, 2026 at 8:45 a.m. ET, announced on November 4, 2026.Read the full analysis →
- The company said revenue for Q3 2026 (three months ended September 30) rose to $3,810.0 million, up 6.9% from $3,563.5 million a year earlier, with diluted EPS at $3.22 and adjusted EPS at $4.78.Read the full analysis →
- Labcorp said its Board of Directors declared a cash dividend of $0.72 per share of common stock on October 21, 2026.Read the full analysis →
Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.
Company overview
Expand ▾
Labcorp (LH) stock information
NYSE
Labcorp (LH) is listed on NYSE. Its market capitalization is about $30B. On trailing-twelve-month earnings the P/E ratio is 29.86, and the P/B ratio is 3.39. Return on equity is 11.4%. These figures are computed in-house from official filings and are reference information only.
Labcorp — frequently asked questions
- What is the P/E ratio of Labcorp (LH)?
- On a trailing-twelve-month basis, LH trades at a P/E ratio of 29.86. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of Labcorp?
- LH has a market capitalization of about $30B. The figure moves with the share price and is refreshed each trading day.
- Does Labcorp pay a dividend?
- LH has a dividend yield of about 0.78%, based on disclosed payment history. Dividend policy can change; this is reference information only.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.